Redefining biologics safety through advanced analytics: MS-based host cell protein profiling
Abstract
Recent regulatory and pharmacopeial guidance highlights attention to host cell protein (HCP) impurities in biologics. Advances in liquid chromatography-mass spectrometry (LC-MS) enable molecular-level characterization of HCPs beyond immunoassay measurements. This article examines how LC-MS-based HCP profiling strengthens impurity risk assessment, improves process understanding, and supports analytical strategies for biologics quality and safety.
Fields of Study & Subjects
Advanced Proteomics Techniques and Applications
Advanced Biosensing Techniques and Applications
vaccines and immunoinformatics approaches
Publication details
- Journal / source
- Trends in biotechnology
- Publisher
- Elsevier BV
- Publication date
- 1 June 2026
- Language
- EN